共 50 条
- [31] ALTERATIONS IN EGF-DEPENDENT PROLIFERATIVE AND PHOSPHORYLATION EVENTS IN SQUAMOUS-CELL CARCINOMA CELL-LINES BY A TYROSINE KINASE INHIBITOR [J]. ANTI-CANCER DRUG DESIGN, 1994, 9 (04): : 311 - 329
- [32] EGF ADMINISTERED ORALLY, STIMULATES GASTRIC CELL-PROLIFERATION IN THE NURSING RAT [J]. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1987, 11 (2BIS): : A236 - A236
- [34] Somatic mutations of the EGF receptor and their signal transducers affect the efficacy of EGF receptor-specific tyrosine kinase inhibitors [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2011, 4 (04): : 403 - 409
- [36] NGFI-A Binding Protein 2 Promotes EGF-Dependent HNSCC Cell Invasion [J]. CANCERS, 2019, 11 (03):
- [38] The endocrine disruptor bisphenol A promotes nuclear ERRγ translocation, facilitating cell proliferation of Grade I endometrial cancer cells via EGF-dependent and EGF-independent pathways [J]. Molecular and Cellular Biochemistry, 2019, 452 : 41 - 50
- [40] Inhibition of the epidermal growth factor (EGF) receptor tyrosine kinase and EGF-dependent phosphorylation of a 58 kDa protein in intact A431 tumor cells induced by nitric oxide. [J]. BIOLOGY OF NITRIC OXIDE, PT 7, 2000, 16 : 134 - 134